Skip to main content

Trokendi XR FDA Approval History

FDA Approved: Yes (First approved August 16, 2013)
Brand name: Trokendi XR
Generic name: topiramate
Company: Supernus Pharmaceuticals, Inc.
Treatment for: Epilepsy

Trokendi XR (topiramate) is an antiepileptic drug indicated for the treatment of epilepsy.

Development timeline for Trokendi XR

Aug 19, 2013Approval Supernus Announces Final FDA Approval and Upcoming Launch of Trokendi XR

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.